Update on tuberous sclerosis complex

Contributions to Nephrology

Volumn 136, Issue , 2001, Pages 33-49

  Torres, V E ^a   King, B F ^a   McKusick, M A ^a   Bjornsson, J ^a   Zincke, H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; REPRESSOR PROTEIN; TUBERIN; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANGIOMYOLIPOMA; CASE REPORT; FEMALE; GENETICS; HUMAN; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUMOR; MUTATION; REVIEW; SPINAL CORD TUMOR; TUBEROUS SCLEROSIS;

ADULT; ANGIOMYOLIPOMA; EPIDURAL NEOPLASMS; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; MUTATION; PROTEINS; REPRESSOR PROTEINS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0035537891     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060178     Document Type: Article

References (42)

1. Digoy G, Tibayan F, Young H, Edelstein P: Adenocarcinoma of the rectum with associated colorectal adenomatous polyps in tuberous sclerosis: A case report. J Pediatr 2000;35:526-527.
2. Gomez H: History of tuberous sclerosis complex; in Gomez M, Sampson J, Whittemore V (eds):Tuberous Sclerosis Complex: Developmental Perspectives in Psychiatry. New York, Oxford University Press, 1999, pp 3-9.
3. Roach E, Gomez M, Northrup H: Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria. J Child Neurol 1998;13:624-628.
4. Green A, Smith M, Yates J: Loss of heterozygosity on chromosome 16pl3.3 in hamartomas from tuberous sclerosis patients. Nat Genet 1994;6:193-196.
5. Green A, Johnson P, Yates J: The tuberous sclerosis gene at chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 1944;3:1833-1834.
6. Henske E, Scheithauer B, Short M, Wollmann R, Nahmias J, Hornigold N, Vanslegtenhorst M, Welsh C, Kwiatkowski D: Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 1996;59:400-406.
7. Torres V, Zincke H, King B, Bjornsson J: Renal manifestations of tuberous sclerosis. Contrib Nephrol. Basel, Karger, 1997, vol 122, pp 64-75.
8. Costello L, Hartman T, Ryu J: High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clini Proc 2000;75:591-594.
9. Shepherd C, Gomez M, Lie J, Crowson C: Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991;66:792-796.
10. Fryer A, Chalmers A, Connor J, Fraser I, Povey S, Yates A, Yates J, Osborne J: Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987;i:659-661.
11. Kandt R, Haines J, Smith M, Northrup H, Gardner R, Short M, Dumars K, Roach E, Steingold S, Wall S, Blanton S, Flodman P, Kwiatkowski D, Jewell A, Weber J, Roses A, Pericakvance M: Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992;2:37-41.
12. Anonymous: Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium. Cell 1993;75:1305-1315.
13. Consortium T: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-808.
14. Van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson J, Halley D, van der Sluijs P: Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 1998;7:1053-1057.
15. Plank T, Yeung R, Henske E: Hamartin, the product of the tuberous sclerosis (TSC1 ) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998;58: 4766-4770.
16. Lamb R, Roy C, Diefenbach T, Vinters H, Johnson M, Jay D, Hall A: The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2000;2:281-287.
17. Xiao GH, Shoarinejad F, Jin F, Golemis E, Yeung R: The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem 1997;272:6097-6100.
18. Henry K, Yuan X, Koszewaki N, Onda H, Kwiatkowski D, Noonan D: Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J Biol Chem 1998;273:20535-20539.
19. Soucek T, Pusch O, Wienecke R, DeClue J, Hengstschlager M: Role of the tuberous sclerosis gene-2 product in cell cycle control. J Biol Chem 1997;272:29301-29308.
20. Ito N, Rubin G: Gigas, a Drosophila homolog of tuberous sclerosis gene product-2 regulates the cell cycle. Cell 1999;96:529-539.
21. Nellist M, van Slegtenhorst M, Goedbloed M, van den Ouweland A, Halley D, van der Sluijs P: Characterization of the cytosolic tuberin-hamartin complex. J Biol Chem 1999;274: 35647-35652.
22. Murthy V, Haddad L, Smith N, Pinney D, Tyszkowski R, Brown D, Ramesh V: Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney. Am J Physiol 2000;278:F737-F746.
23. Jones A, Shyamsundar M, Thomas M, Maynard J, Idziaszczyk S, Tomkins S, Sampson J, Cheadle J: Comprehensive mutation analysis of TSC1 and TSC2, and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999;64:1305-1315.
24. Niida Y, Lawrence-Smith N, Banwell A, Hammer E, Lewis J, Beauchamp R, Sims K, Ramesh V, Ozelius L: Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosi. Hum Mutat 1999;14:412-422.
25. Van Slegtenhorst M, Verhoef S, Tempelaars A, Bakker L, Wang Q, Wessels M, Bakker R, Nellist M, Lindhout D, Halley D, van den Ouweland A: Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: No evidence for genotype-phenotype correlation. J Med Genet 1999;36:285-289.
26. Verhoef S, Bakker L, Tempelaars A, Mazurczak T, Jozwiak S, Fois A, Bartalini G, Zonnenberg B, van Essen A, Lindhout D, Halley D, van den Ouweland A: High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet 1999;64:1305-1315.
27. Zhang H, Nanba E, Yamamoto T, Ninomiya H, Ohno K, Mizuguchi M, Takeshita K: Mutational analysis of TSC1 and TSC2 genes in Japanese patients with tuberous sclerosis complex. J Hum Genet 1999;44:391-396.
28. Torres Y King B, Holley K, Blute M, Gomez M: The kidney in the tuberous sclerosis complex. Adv Nephrol Necker Hosp 1994;23:43-70.
29. Oesterling J, Fishman E, Goldman S, Marshall F: The management of renal angiomyolipoma. J Urol 1986;135:1121-1124.
30. Bjornsson J, Short M, Kwiatkowski D, Henske E: Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol 1996;149:1201-1208.
31. Eble J, Amin M, Young R: Epithelioid angiomyolipoma of the kidney: A report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol 1997;21:1123-1130.
32. Pea M, Bonetti F, Martignoni G, Henske E, Manfrin E, Colato C, Bernstein J: Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: The identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol 1998;22:180-187.
33. Hino O, Fukuda T, Satake N, Kobayashi T, Honda S, Orimoto K, Yamashita Y, Kikuchi Y: TSC2 gene mutant (Eker) rat model of a mendelian dominantly inherited cancer; in Hiai H, Hino O (eds): Animal Models of Cancer Predisposition Syndromes. Prog Exp Tumor Res. Basel, Karger, 1999, vol 35, pp 95-108.
34. Yamashita Y, Yokoyama M, Kobayashi E, Takai S, Hino O: Mapping and determination of the cDNA sequence of the Ere gene preferentially expressed in renal cell carcinoma in the Tsc2 gene mutant (Eker) rat model. Biochem Biophys Res Commun 2000;275:134-140.
35. Kobayashi T, Minowa O, Kuno J, Mitani H, Hino O, Noda T: Renal carcinogenesis, hepatic heman-giomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res 1999;59:1206-1211.
36. Satake N, Urakami S, Hirayama Y, Izumi K, Hino O: Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma. Int J Cancer 1998;77:895-900.
37. Saguem M, Laarif M, Remadi S, Bozakoura C, Cox J: Diffuse bilateral glomerulocystic disease of the kidneys and multiple cardiac rhabdomyomas in a newborn. Relationship with tuberous sclerosis and review of the literature. Pathol Res Pract 1992;188:367-373.
38. Bernstein J: Renal cystic disease in the tuberous sclerosis complex. Pediatr Nephrol 1993;7: 490-495.
39. Sampson J, Maheshwar M, Aspinwall R, Thompson P, Cheadle J, Ravine D, Roy S, Haan E, Bernstein J, Harris P: Renal cystic disease in tuberous sclerosis: Role of the polycystic kidney disease 1 gene. Am J Hum Genet 1997;61:843-851.
40. Torres V, Bjornsson J, King B, Kumar R, Zincke H, Edell E, Wilson T, Hattery R, Gomez M: Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex. Mayo Clini Proc 1995;70:641-648.
41. Nagashima Y, Ohaki Y, Tanaka Y, Misugi K, Horiuchi M: A case of renal angiomyolipomas associated with multiple and various hamartomatous microlesions. Virchows Arch A 1988;413: 177-182.
42. Kilicaslan I, Gulluoglu M, Dogan O, Uysal V: Intraglomerular microlesions in renal angiomyolipoma. Hum Pathol 2000;31:1325-1328.